lexaptepid pegol (NOX H94) / TME Pharma 
Welcome,         Profile    Billing    Logout  
 18 Diseases   0 Trials   0 Trials   15 News 
  • ||||||||||  lexaptepid pegol (NOX H94) / TME Pharma
    Enrollment closed, Trial primary completion date:  Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients (clinicaltrials.gov) -  Oct 6, 2015   
    P1/2,  N=32, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015
  • ||||||||||  lexaptepid pegol (NOX H94) / TME Pharma
    Enrollment change, Trial primary completion date:  Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients (clinicaltrials.gov) -  Dec 5, 2014   
    P1/2,  N=32, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015 N=20 --> 32 | Trial primary completion date: Nov 2014 --> Aug 2015